Compare Sanofi SA (SNY) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs TeraWulf Inc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while TeraWulf Inc trades at $19.95 (market cap $9.35B). The key difference: Sanofi SA is far larger — about 11.2× TeraWulf Inc's market cap, and Sanofi SA pays a 5.5% dividend while TeraWulf Inc pays none. Which is the better fit depends on your goals.
| SNY | WULF | |
|---|---|---|
Market Cap | $104.83B | $9.35B |
Sector | Health | Technology |
52-Week High | $52.34 | $28.98 |
52-Week Low | $41.33 | $4.76 |
Enterprise Value | $121.32B | $12.03B |
Dividend Yield | 5.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
